The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / Earwax Lipids Offer Clues to Ménières
Biochemistry and molecular biology Analytical science Technology and innovation

Earwax Lipids Offer Clues to Ménière’s

The experimental method combines rapid chemical profiling with targeted fatty acid measurement

10/09/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Objective:

To investigate whether chemical patterns in earwax could distinguish people with Ménière’s disease from those without it.

Approach:
  • Study design: A 2023 pilot study analyzed earwax from 15 people: seven without Ménière’s disease and eight with confirmed or tentative disease.
  • Methods: Researchers used direct analysis in real time-high-resolution mass spectrometry to profile samples and gas chromatography-mass spectrometry to identify and measure compounds.
  • Model testing: Statistical modeling used six samples from each group; the classification model was also tested on three additional samples.
Key Findings:
  • Three fatty acids—cis-9-hexadecenoic acid, cis-10-heptadecenoic acid, and cis-9-octadecenoic acid—were present in both groups but at lower concentrations in the Ménière’s disease group.
  • In targeted analysis, average concentrations were approximately 78%, 85%, and 58% lower, respectively, in the disease group.
  • The model categorized three additional samples correctly, but its internal classification performance was described as modest.
Interpretation:

The pilot findings indicate that earwax contains measurable biochemical patterns associated with Ménière’s disease, but they do not establish earwax analysis as a diagnostic test. The mass spectrometry-based technology remains at an early laboratory stage and has not been validated for clinical diagnosis.

Limitations:
  • The study included few participants, and testing on three additional samples is insufficient to establish diagnostic accuracy.
  • Larger prospective studies are needed to determine sensitivity and specificity and to compare Ménière’s disease with other vestibular disorders.
  • The effects of age, genetics, medication, diet, ear-cleaning practices, and sample collection on fatty acid levels remain to be assessed.
Conclusion:

The Research Foundation for the State University of New York announced that the test is available for licensing; a US patent application is pending.

Sources:
  • Article context; source URL not provided

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.